Clinical trial
Comparative Trial of Pivanex and Docetaxel Vs Docetaxel Monotherapy in Patients…
NCT00073385 · Titan Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00073385 |
|---|---|
| Title | Comparative Trial of Pivanex and Docetaxel Vs Docetaxel Monotherapy in Patients With Advanced Non-Small Cell Lung Cancer |
| Official title | A Randomized Trial of Pivanex Plus Docetaxel or Docetaxel Monotherapy in Patients With Chemotherapy Resistant Advanced Non-Small Cell Carcinoma of the Lung (NSCLC) |
| Lead sponsor | Titan Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma, Non-Small-Cell Lung |
| Intervention type | Drug |
| Interventions | Pivanex, Docetaxel |
| Enrollment | 225 |
| Start date | Sep 1, 2003 |
| Completion | Oct 1, 2004 |
| First posted | Nov 21, 2003 |
| Last update posted | Aug 30, 2005 |
| Countries | India, United Kingdom, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: